198 results
Page 2 of 10
8-K
uchay
15 Nov 23
Alkermes Completes Separation of Oncology Business
7:05am
8-K
EX-10.1
4rohe
15 Nov 23
Alkermes Completes Separation of Oncology Business
7:05am
8-K
EX-99.1
n28supx j6dyb
31 Oct 23
Alkermes Announces Effectiveness of Mural Oncology Form 10 Registration Statement
5:18pm
8-K
EX-99.1
k7l7zm m7nm6cs99
25 Oct 23
Alkermes plc Reports Third Quarter 2023 Financial Results
7:06am
8-K
EX-99.1
nvhaq4
23 Oct 23
Alkermes Presents First Clinical Data for Orexin 2 Receptor Agonist ALKS 2680 at World Sleep Congress
8:27am
8-K
EX-99.1
rk3aq9tsg3gz3rcr 31
30 Aug 23
Alkermes Announces Settlement With Teva Related to VIVITROL® Patent Litigation
7:14am
8-K
EX-99.1
ga1 vo9bjrzvq4dp
26 Jul 23
Alkermes plc Reports Second Quarter 2023 Financial Results
7:06am
DFAN14A
g4bgs06orhm9jf 9nf8
26 Jun 23
Additional proxy materials by non-management
5:00pm
DEFA14A
e3ovi40quq m9lt
26 Jun 23
Additional proxy soliciting materials
4:45pm
DEFA14A
wh3uflwif8zg gb5s38
26 Jun 23
Additional proxy soliciting materials
7:05am
DEFA14A
iuoqs1c8j7 rqbgxy
21 Jun 23
Additional proxy soliciting materials
9:30am
DEFA14A
wrfdp
21 Jun 23
Additional proxy soliciting materials
8:06am
DEFA14A
3xa69hs
20 Jun 23
Additional proxy soliciting materials
7:11am
DFAN14A
zreid39 n7d
13 Jun 23
Additional proxy materials by non-management
4:30pm
DEFA14A
o7ettmfjje2 kmq08wm
13 Jun 23
Additional proxy soliciting materials
7:08am
DEFA14A
mzg5aov
12 Jun 23
Additional proxy soliciting materials
9:00am
DEFA14A
t7yzb 6dfkh
8 Jun 23
Additional proxy soliciting materials
7:30am